Search results
Novartis raises full-year sales and profit guidance after strong Q1
Proactive Investors· 5 days agoNovartis AG (ADR) (NYSE:NVS) has raised its full-year revenue and profit guidance following a strong...
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoNovartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of the...
Novartis AG (NYSE:NVS) Expected to Post Q3 2025 Earnings of $1.98 Per Share
ETF DAILY NEWS· 4 days agoNovartis AG (NYSE:NVS – Free Report) – Analysts at Zacks Research cut their Q3 2025 earnings per share estimates for shares of Novartis in a note issued ...
Novartis: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 5 days agoBASEL, Switzerland (AP) — BASEL, Switzerland (AP) — Novartis AG (NVS) on Tuesday reported first-quarter profit of $2.69 billion. The Basel, Switzerland-based ...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 5 days agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Cwm LLC Sells 1,204 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 5 days agoCwm LLC lessened its position in Novartis AG (NYSE:NVS – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing ...
Top Analyst Reports for Novartis, American Express & ConocoPhillips
Zacks via Yahoo Finance· 6 days agoToday's Research Daily features new research reports on 16 major stocks, including Novartis AG...
Novartis Q1 Profit Tops Market, Lifts FY24 View, Proposes New Chair; Stock Up
RTT News· 5 days agoNovartis AG's shares were gaining more than 4 percent in Switzerland and more than 5 percent in pre-market activity on the NYSE after the Swiss drug major ...
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and...
Zacks via Yahoo Finance· 5 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic...
Benzinga via Yahoo Finance· 4 days agoTuesday, Novartis AG (NYSE:NVS) received FDA approval for its Lutathera (lutetium Lu 177 dotatate /...